179
Views
0
CrossRef citations to date
0
Altmetric
Review Article

The impact of the COVID-19 pandemic on medications for opioid use disorder services in the U.S. and Canada: a scoping review

ORCID Icon, , ORCID Icon & ORCID Icon
Pages 529-542 | Received 23 Aug 2022, Accepted 08 Feb 2023, Published online: 21 Feb 2023
 

Abstract

Background

Since the arrival of the COVID-19 pandemic, preliminary evidence suggests that rates of opioid use and overdose in North America have only been exacerbated. During this time, healthcare services providing medications for opioid use disorder (MOUD) have faced heightened challenges, rapidly adjusting services in order to continue to provide access to treatment. To better understand the impact of the pandemic on MOUD services in the U.S. and Canada, this scoping review summarizes and synthesizes the existing literature on this topic.

Methods

Articles were deemed eligible to be included in this review if they met the following three criteria: focused on MOUD services; situated within the COVID-19 pandemic; and situated within the U.S. or Canada.

Results

Common themes among the articles that met inclusion included the impacts of MOUD policy changes; the transition to telehealth; challenges to providing MOUD; innovative changes to services; and recommendations for policy and service changes. Many articles supported MOUD regulatory changes, with some finding these changes had increased access to MOUD for underserved populations.

Conclusions

There is currently a pressing need to evaluate the impacts on MOUD services in greater depth, as recent changes could have lasting implications on future MOUD regulatory policies and treatment standards.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This work was supported by the Canadian Institutes of Health Research under Grant MS4-173112. Daniel Parker is supported by a SSHRC Doctoral Award from the Social Sciences and Humanities Research Council of Canada. Dr. Wendt is supported by a Chercheur-Boursier Award from the Fonds de recherche du Québec – Santé.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.